Peptides DB
Research-centric peptide and protocol reference hub

DSIP vs SS-31

Updated July 29, 2026 · Reviewed by the PeptidesDB Editorial team

DSIP: Research use — not FDA-approvedSS-31: Research use — not FDA-approved

A data-driven comparison of DSIP and SS-31 (also searched as SS-31 vs DSIP) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

DSIP centers on sleep, while SS-31 leans toward inflammation. On indexed research, SS-31 is ahead (DSIP: 7 studies, Human evidence; SS-31: 19, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • DSIP is strongest for sleep; SS-31 for inflammation.
  • Evidence: DSIP Human evidence (7 studies) vs SS-31 Human evidence (19).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

DSIP: Healing 1.0, Muscle 0.0, Metabolic 1.0, Neuro 3.0, Sleep 5.0, Immune 2.0, Skin 0.0 — SS-31: Healing 3.0, Muscle 2.0, Metabolic 4.0, Neuro 3.0, Sleep 1.0, Immune 4.0, Skin 0.0Healing & recovery — 1.0 / 5 · DSIPMetabolic & appetite — 1.0 / 5 · DSIPNeuro & mood — 3.0 / 5 · DSIPSleep & circadian — 5.0 / 5 · DSIPInflammation & immune — 2.0 / 5 · DSIPHealing & recovery — 3.0 / 5 · SS-31Muscle & body comp — 2.0 / 5 · SS-31Metabolic & appetite — 4.0 / 5 · SS-31Neuro & mood — 3.0 / 5 · SS-31Sleep & circadian — 1.0 / 5 · SS-31Inflammation & immune — 4.0 / 5 · SS-31HealingMuscleMetabolicNeuroSleepImmuneSkin
DSIPSS-31

At a glance

DSIPHuman evidence

Delta Sleep-Inducing Peptide | Sleep & Stress Modulator

Strongest: SleepStudies: 7Level: Emerging
SS-31Human evidence

Mitochondrial-Targeted Peptide | Cardiolipin Protector

Strongest: InflammationStudies: 19Level: Well Studied

DSIP vs SS-31: side-by-side

MetricDSIPSS-31
ClassSleepLongevity
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman evidence
Studies indexed719
Research levelEmergingWell Studied
Strongest effectSleep & circadianInflammation & immune
Healing & recovery1.03.0
Muscle & body comp0.02.0
Metabolic & appetite1.04.0
Neuro & mood3.03.0
Sleep & circadian5.01.0
Inflammation & immune2.04.0
Skin & aesthetics0.00.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyDSIPSS-31
MechanismTargets inner mitochondrial membrane to enhance function and reduce ROS
RouteSubcutaneous injection

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is DSIP?

Delta Sleep-Inducing Peptide, primarily discussed for sleep quality, stress modulation, and pain.

Full DSIP profile, mechanism & studies →

What is SS-31?

### Summary SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.

Full SS-31 profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingSS-313.0/5 effect signal
MuscleSS-312.0/5 effect signal
MetabolicSS-314.0/5 effect signal
NeuroEvenBoth ~3.0/5
SleepDSIP5.0/5 effect signal
InflammationSS-314.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack DSIP and SS-31?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

DSIP vs SS-31: side effects

DSIP

No community-reported effects logged yet.

SS-31

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

DSIP has 7 approved studies indexed (Human evidence), and SS-31 has 19 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is DSIP or SS-31 better?

It depends on your goal. DSIP is strongest for sleep; SS-31 for inflammation. SS-31 has more indexed studies (19). See the goal-by-goal breakdown above.

Is DSIP or SS-31 better for weight loss?

SS-31 shows the stronger metabolic & appetite profile (4.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is DSIP or SS-31 better for muscle?

SS-31 leads on the muscle & body-composition axis (2.0/5).

Which has more research, DSIP or SS-31?

DSIP has 7 approved studies indexed (Human evidence); SS-31 has 19 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack DSIP and SS-31?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of DSIP vs SS-31?

DSIP: no community-reported effects logged yet. SS-31: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is DSIP or SS-31 FDA-approved?

DSIP is a research-use compound and is not FDA-approved. SS-31 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is SS-31 better than DSIP?

For inflammation, SS-31 has the edge; for sleep, DSIP does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

DSIP and SS-31 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 29, 2026.